BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Potential Device Malfunction Forces Apotex to Recall One Lot of Its Apo-Nitroglycerin Sublingual Spray

  September 5, 2017

   · 

  2 min read
• Policy

  Amerigen Pharmaceuticalsen Believes That It Is A First Applicant To File An Abbreviated New Drug Application (“ANDA”) For Certain Strengths Of Namzaric Containing A “Paragraph IV” Patent Certification Under The Provisions Of The Hatch-Waxman Act

  September 5, 2017

   · 

  2 min read
• Drug Development

  EMD Serono Release: Investigational Cladribine Tablets Demonstrates Sustained Disease Control Over 4 Years With Maximum Of 20 Days Oral Treatment

  September 5, 2017

   · 

  7 min read
• Drug Development

  Acceleron Pharma Announces Publication Of Luspatercept Phase 2 Myelodysplastic Syndromes Study Results In The Lancet Oncology

  September 5, 2017

   · 

  5 min read
• Drug Development

  EnGeneIC Pty Ltd Announces Publication In The Lancet Oncology Of First Clinical Study Employing EDV Nanocell Platform to Enable microRNA Replacement Therapy

  September 5, 2017

   · 

  3 min read
• Business

  Cannimed Announces 2017 Third Quarter Results Release Date

  September 5, 2017

   · 

  2 min read
• FDA

  European Commission (EC) Approves Merck & Co.’s KEYTRUDA (Pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer

  September 5, 2017

   · 

  1 min read
• Drug Development

  Bellerophon Therapeutics Announces Positive Top Line Phase II Data Of INOpulse For Treatment Of Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease

  September 5, 2017

   · 

  5 min read
• Business

  Christopher Rieder Joins Aurora Diagnostics Inc. As Chief Information Officer

  September 5, 2017

   · 

  2 min read
• Jazz Pharma Announces Completion Of Offering And Exercise In Full Of Initial Purchasers’ Option To Purchase Additional 1.50% Exchangeable Senior Notes Due 2024

  September 5, 2017

   · 

  3 min read